Cyclooxygenase inhibition and vascular reactivity in a rat model of hyperdynamic sepsis

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 1, 1996, Pages 30-35

  Fox, George A ^b   Paterson, Nigel A M ^b   McCormack, David G ^a   Rohan, Marta ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

Cecal ligation and perforation; Cyclooxygenase; Meclofenamate; Prostaglandins; Sepsis

Indexed keywords

MECLOFENAMIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HEART OUTPUT; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG CIRCULATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; SEPSIS; SMOOTH MUSCLE CONTRACTILITY; VASCULAR RESISTANCE;

ANIMALS; ANOXIA; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HEMODYNAMIC PROCESSES; MALE; MECLOFENAMIC ACID; PHENYLEPHRINE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; THROMBOXANE B2; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0029942143     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199607000-00006     Document Type: Article

References (37)

1. Fink MP, Homer LD, Fletcher JR. Diminished presser response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin-mediated effect. J Surg Res 1985;38:335-42.
2. Burnier M, Waeber B, Aubert JF, Nussberger J, Brunner HR. Effects of nonhypotensive endotoxemia in conscious rats; role of prostaglandins. Am J Physiol 1988;254;H509-16.
3. 2 formation is increased in human sepsis syndrome. Am Rev Respir Dis 1991;144:1095-101.
4. Weir EK, Milczoch J, Reeves JT, Grover RF. Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J Lab Clin Med 1976;68:975-83.
5. Begley CJ, Ogletree ML, Meyrick BO, Brigham KL. Modification of pulmonary responses to endotoxemia in awake sheep by steroidal and nonsteroidal antiinflammatory agents. Am Rev Respir Dis 1984;130:1140-6.
6. Demling RH, LaLonde C, Goad MEP. Effect of ibuprofen on the pulmonary and systemic response to repeated doses of endotoxin. Surgery 1989;105:421-9.
7. Hanly PJ, Dobson K, Roberts D, Light RB. Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia. Lancet 1987;1:351-4.
8. Nishijima MK, Breslow MJ, Miller CF, Traystman RJ. Effect of nalaxone and ibuprofen on organ blood flow during endotoxic shock in pig. Am J Physiol 1988;255:H177-84.
9. Hanly PJ, Sienko A, Light RB. Role of prostacyclin and thromboxane in the circulatory changes of acute bacteremic Pseudomonas pneumonia in dogs. Am Rev Respir Dis 1988;137:700-6.
10. 2 metabolism in endotoxic pigs: effect of ibuprofen and meclofenamate. J Appl Physiol 1989;67:1950-7.
11. 2 mediates lung vasoconstriction but not permeability after endotoxin. J Clin Invest 1983;72:911-8.
12. Graham LM, Vasil A, Vasil ML, Voelkel NF, Stenmark KR. Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia. Am Rev Respir Dis 1990;142:221-9.
13. Dantzker DR, Brook CJ, Dehart P, Lynch JP, Weg JG. Ventilation-perfused distributions in the adult respiratory distress syndrome. Am Rev Respir Dis 1979;120:1039-52.
14. Light RB, Mink SN, Wood LDH. Pathophysiology of gas exchange and pulmonary perfusion in pneumococcal lobar pneumonia in dogs. J Appl Physiol 1981;50:524-30.
15. Hanly P, Light RB. Lung mechanics, gas exchange, pulmonary perfusion, and hemodynamics in a canine model of acute Pseudomonas pneumonia. Lung 1987;165:305-22.
16. Esbenshade AM, Newman JH, Lams PM, Jolles H, Brigham KL. Respiratory failure after endotoxin infusion in sheep: lung mechanics and fluid balance. J Appl Physiol 1982;53:967-76.
17. Brigham KL, Bowers RE, Haynes J. Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ Res 1979;45:292-7.
18. McCormack DG, Crawley D, Barnes PJ, Evans TW. Bleomycin-induced lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor, din Sci 1992;82:259-64.
19. Hales CA, Sonne L, Peterson M, Kong D, Miller M, Watkins WD. Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest 1981;68:497-505.
20. Byrne K, Sielaff TD, Michna B, et al. Increased survival time after delayed histamine and prostaglandin blockade in a porcine model of severe sepsis-induced lung injury. Crit Care Med 1990;18:303-8.
21. Jenkins JK, Carey PD, Byrne K, Sugerman HJ, Fowler AA. Sepsis-induced lung injury and the effects of ibuprofen pretreatment. Am Rev Respir Dis 1991;143:155-61.
22. Fox G, Paterson N, McCormick D. Attenuated hypoxic pulmonary vasoconstriction in-vivo in a rat model of hyperdynamic sepsis [Abstract]. Am Rev Respir Dis 1992;145:A629.
23. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. J Appl Physiol 1979;236:818-27.
24. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 1980;29:189-201.
25. Fox GA, Paterson NAM, McCormack DG. Effect of inhibition of NO synthase on vascular reactivity in a rat model of hyperdynamic sepsis. Am J Physiol 1994;267:H1377-82.
26. Martin CM, Yaghi A, Sibbald WJ, McCormack D, Paterson NAM. Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am Rev Respir Dis 1993;148:164-72.
27. Brackett DJ, Schaefer CF, Tompkins P, Fagraeus L, Peters LJ, Wildon MF. Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia. Circ Shock 1985;17:273-84.
28. Harris RL, Musher DM, Bloom K, et al. Manifestations of sepsis. Arch Intern Med 1987;147:1895-906.
29. Chernow B, Rainey TG, Lake CR. Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 1982;10:409-16.
30. Chernow B, Roth BL. Pharmacologic manipulation of the peripheral vasculature in shock: clinical and experimental approaches. Circ Shock 1986;18:141-55.
31. Wisner D, Sturm J, Sutter G, Ellendorf B, Nerlich M. Thromboxane receptor blockade in an animal model of ARDS. Surgery 1988;104:91-7.
32. Traber DL, Adair TH, Adams T. Hemodynamic consequences of endotoxemia in sheep. Circ Shock 1981;8:551-61.
33. Palsson J, Ricksten SE, Lundin S. Changes in central hemodynamics during experimental septic shock in conscious rats. Circ Shock 1987;22:65-72.
34. 2 synthesis in experimental septic shock. Circ Shock 1988;26:27-40.
35. Newman JH, McMurtry IF, Reeves JT. Blunted pulmonary pressor responses to hypoxia in blood perfused, ventilated lungs isolated from oxygen toxic rats: possible role of prostaglandins. Prostaglandins 1981;22:11-20.
36. Voelkel NF. Mechanisms of hypoxic pulmonary vasoconstriction. Am Rev Respir Dis 1986;133:1186-95.
37. Hutchison AA, Ogletree ML, Snapper JR, Brigham KL. Effect of endotoxemia of hypoxic pulmonary vasoconstriction in unanesthetized sheep. J Appl Physiol 1985;58:1463-8.